WallStSmart

America Movil SAB de CV ADR (AMX)vsHCA Holdings Inc (HCA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

America Movil SAB de CV ADR generates 1142% more annual revenue ($948.44B vs $76.39B). AMX leads profitability with a 9.2% profit margin vs 8.9%. AMX appears more attractively valued with a PEG of 1.18. AMX earns a higher WallStSmart Score of 65/100 (C+).

AMX

Buy

65

out of 100

Grade: C+

Growth: 5.3Profit: 7.0Value: 6.3Quality: 4.0
Piotroski: 6/9Altman Z: 1.37

HCA

Buy

63

out of 100

Grade: C+

Growth: 5.3Profit: 8.0Value: 6.0Quality: 6.0
Piotroski: 5/9Altman Z: 1.71
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for AMX.

HCAFair Value (-4.8%)

Margin of Safety

-4.8%

Fair Value

$507.35

Current Price

$435.19

$72.16 premium

UndervaluedFair: $507.35Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMX6 strengths · Avg: 8.3/10
Market CapQuality
$80.46B9/10

Large-cap with strong market position

Return on EquityProfitability
21.1%9/10

Every $100 of equity generates 21 in profit

P/E RatioValuation
16.0x8/10

Attractively priced relative to earnings

Operating MarginProfitability
21.3%8/10

Strong operational efficiency at 21.3%

EPS GrowthGrowth
25.8%8/10

Earnings expanding 25.8% YoY

Free Cash FlowQuality
$3.27B8/10

Generating 3.3B in free cash flow

HCA4 strengths · Avg: 9.3/10
Return on EquityProfitability
136.3%10/10

Every $100 of equity generates 136 in profit

Debt/EquityHealth
-8.3310/10

Conservative balance sheet, low leverage

Market CapQuality
$95.17B9/10

Large-cap with strong market position

P/E RatioValuation
14.8x8/10

Attractively priced relative to earnings

Areas to Watch

AMX3 concerns · Avg: 2.3/10
Revenue GrowthGrowth
2.1%4/10

2.1% revenue growth

Altman Z-ScoreHealth
1.372/10

Distress zone — elevated risk

Debt/EquityHealth
2.531/10

Elevated debt levels

HCA2 concerns · Avg: 4.0/10
Revenue GrowthGrowth
4.3%4/10

4.3% revenue growth

Altman Z-ScoreHealth
1.714/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : AMX

The strongest argument for AMX centers on Market Cap, Return on Equity, P/E Ratio. PEG of 1.18 suggests the stock is reasonably priced for its growth.

Bull Case : HCA

The strongest argument for HCA centers on Return on Equity, Debt/Equity, Market Cap. PEG of 1.29 suggests the stock is reasonably priced for its growth.

Bear Case : AMX

The primary concerns for AMX are Revenue Growth, Altman Z-Score, Debt/Equity. Debt-to-equity of 2.53 is elevated, increasing financial risk.

Bear Case : HCA

The primary concerns for HCA are Revenue Growth, Altman Z-Score.

Key Dynamics to Monitor

HCA carries more volatility with a beta of 1.19 — expect wider price swings.

HCA is growing revenue faster at 4.3% — sustainability is the question.

AMX generates stronger free cash flow (3.3B), providing more financial flexibility.

Monitor TELECOM SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

AMX scores higher overall (65/100 vs 63/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

America Movil SAB de CV ADR

COMMUNICATION SERVICES · TELECOM SERVICES · USA

Amrica Mvil, SAB de CV provides telecommunications services in Latin America and internationally. The company is headquartered in Mexico City, Mexico.

Visit Website →

HCA Holdings Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

HCA Healthcare is an American for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owns and operates 186 hospitals and approximately 2,000 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 21 states and the United Kingdom.

Visit Website →

Want to dig deeper into these stocks?